Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia
For infants receiving systemic dexamethasone for severe respiratory failure, a combination of clinical characteristics and magnitude of respiratory support may reliably predict inability to wean from positive pressure ventilation, potentially avoiding ineffective dexamethasone exposure. Further validation is required before clinical use.
Authors
- James Benedict Rowe (ORCID: https://orcid.org/0000-0001-7216-8679)
- Erik B. Hysinger (ORCID: https://orcid.org/0000-0002-9222-898X)
- Paul S. Kingma (ORCID: https://orcid.org/0000-0001-7065-8711)
- Melissa House (ORCID: https://orcid.org/0000-0003-1426-5889)
- Shawn K. Ahlfeld
- Avril Walters
- Thomas Nienaber (ORCID: https://orcid.org/0000-0002-1972-7002)
- Chunyan Liu (ORCID: https://orcid.org/0000-0002-2256-8954)
- Shelley R. Ehrlich
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Emory University (US)
- Perinatal Institute (GB)
- Children's Healthcare of Atlanta (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/ppul.71275
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00